Laurion Capital Management LP Protalix Bio Therapeutics, Inc. Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding PLX
# of Institutions
58Shares Held
6.65MCall Options Held
217KPut Options Held
16K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$3.59 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$2.59 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$2.07 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.483KShares$1.46 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$1.17 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $150M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...